[go: up one dir, main page]

Zunino et al., 1979 - Google Patents

Molecular structural effects involved in the interaction of anthracyclines with DNA

Zunino et al., 1979

Document ID
13216240067825747764
Author
Zunino F
Di Marco A
Zaccara A
Publication year
Publication venue
Chemico-Biological Interactions

External Links

Snippet

Abstract Changes in DNA binding ability of daunomycin following structural modifications in the aglycone moiety have been studied by the fluorescence quenching method and by thermal denaturation of the complex. Removal of the methoxyl group at position 4 leads to a …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid

Similar Documents

Publication Publication Date Title
Di Marco et al. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety
Bodley et al. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA
DuVernay Jr et al. Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure-activity relationships of marcellomycin and its analogs as compared to adriamycin
Di Marco et al. Daunomycin (daunorubicin) and adriamycin and structural analogues: biological activity and mechanism of action
Alper et al. Probing the specificity of aminoglycoside− ribosomal RNA interactions with designed synthetic analogs
Povirk et al. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid
Zunino et al. Molecular structural effects involved in the interaction of anthracyclines with DNA
Weenen et al. Pharmacokinetics of 4′-epi-doxorubicin in man
WO1997034612A1 (en) Bis-anthracyclines with high activity against doxorubicin resistant tumors
US20080214845A1 (en) Antibacterial 6'-modified 4,5-substituted aminoglycoside analogs
Cherif et al. N-(5, 5-diacetoxypent-1-yl) doxorubicin: a new intensely potent doxorubicin analog
Wilson et al. Structure-activity relation of daunorubicin and its peptide derivatives
CN114957357A (en) Aminoglycoside derivatives and their use in the treatment of genetic disorders
Shi et al. Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo [b] thiophenes and 2-phenyl-benzo [b] furans
Ramakrishnan et al. 7-Deoxydaunomycinone quinone methide reactivity with thiol nucleophiles
Sinha et al. Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study
US6437105B1 (en) Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
Seeber et al. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and-resistant Ehrlich ascites in vitro
Zunino et al. Steric influence of the orientation of the primary amino group at position 3 of the sugar moiety of anthracycline antibiotics in DNA binding properties
Voldoire et al. Rebeccamycin analogues from indolo [2, 3-c] carbazole
Anizon et al. Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety
Hacker et al. N6-(Δ2-ISOpentenyl) adenosine—effects upon nucleic acid synthesis in lymphocytes in vitro and the development of immunologic hypersensitivity in vivo
Grunberger et al. Modification of ribonucleic acid by chemical carcinogens: VI. Effect of N-2-acetylaminofluorene modification of guanosine on the codon function of adjacent nucleosides in oligonucleotides
CN105273064B (en) Double target spot AntiHIV1 RT activity glycopeptide compounds and its application
IKEGAMI et al. Topostin, a novel inhibitor of mammalian DNA topoisomerase I from Flexibacter topostinus sp. nov. II. Purification and some properties of topostin